Voir le document 

Afficher la notice abrégée

Plasma asymmetric dimethylarginine concentrations are not related to differences in maximal oxygen uptake in endurance trained and untrained men

dc.rights.licenseOTHen_US
dc.contributor.authorPawlak-Chaouch, Mehdi
dc.contributor.authorBoissière, Julien
dc.contributor.authorMunyaneza, Désiré
dc.contributor.authorTagougui, Semah
dc.contributor.authorGamelin, François-Xavier
dc.contributor.authorCuvelier, Grégory
dc.contributor.authorHeyman, Elsa
dc.contributor.authorGoossens, Jean-François
dc.contributor.authorDescat, Amandine
dc.contributor.authorBerthoin, Serge
dc.contributor.authorAucouturier, Julien
dc.date.accessioned2021-04-28T09:52:27Z
dc.date.available2021-04-28T09:52:27Z
dc.date.issued2018-11-22
dc.identifier.issn1469-445Xen_US
dc.identifier.urihttps://luck.synhera.be/handle/123456789/916
dc.identifier.doihttps://doi.org/10.1113/EP087398en_US
dc.description.abstractAsymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthesis that could limit oxygen (O2) delivery in the working skeletal muscles by altering endothelium‐dependent vasodilatation. Exercise capacity is associated with plasma ADMA concentrations in patients with cardiovascular diseases, but this issue has still not been investigated in healthy subjects. We aimed to determine whether plasma ADMA concentrations were negatively associated with exercise capacity in young healthy male subjects.en_US
dc.description.sponsorshipPRVen_US
dc.language.isoENen_US
dc.publisherWiley & Sonsen_US
dc.relation.ispartofExperimental Physiologyen_US
dc.rights.urihttps://authorservices.wiley.com/asset/Article_Sharing_Guidelines.pdfen_US
dc.subjectcardiovascular biomarkeren_US
dc.subjectnitric oxideen_US
dc.subjectoxygen uptakeen_US
dc.subject.frBiomarqueurs sanguinsen_US
dc.subject.frMonoxyde d'azoteen_US
dc.subject.frConsommation d'oxygèneen_US
dc.titlePlasma asymmetric dimethylarginine concentrations are not related to differences in maximal oxygen uptake in endurance trained and untrained menen_US
dc.typeArticle scientifiqueen_US
synhera.classificationSciences de la santé humaine>>Santé publique, services médicaux & soins de santéen_US
synhera.classificationSciences de la santé humaine>>Orthopédie, rééducation & médecine sportiveen_US
synhera.classificationSciences de la santé humaine>>Médecine de laboratoire & technologie médicaleen_US
synhera.institutionHE Condorceten_US
synhera.otherinstitutionUniversité d'Artois, Lilleen_US
synhera.otherinstitutionMontreal Clinical Research Institute (IRCM)en_US
synhera.cost.total0en_US
synhera.cost.apc0en_US
synhera.cost.comp0en_US
synhera.cost.acccomp0en_US
dc.description.versionOuien_US
dc.rights.holder0en_US


Fichier(s) constituant ce document

Thumbnail
Nom:
PUBLI_2018_ADMA.pdf
Taille:
885.0Ko
Format:
PDF
Voir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée